Loading...
UM School of Medicine Researchers Receive Federal Funding to Rapidly Test New Treatments for COVID-19
Authors
Advisor
Date
2020-06-16
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Other Titles
See at
Abstract
New release announcing that the University of Maryland School of Medicine will partner with the government's Defense Advanced Research Projects Agency (DARPA) to rapidly test drugs created for other conditions to determine their effectiveness in treating or preventing COVID-19, the disease caused by the SARS-CoV-2 coronavirus.
Data Availibility
Data / Code Location
Table of Contents
Description
Citations
Altmetric:
Series/Report No.
Sponsors
Rights/Terms
Keyword
Coronavirus Disease 2019 (COVID-19)
Frieman, Matthew B.
Jackson, William T.
Rasko, David A.
Ernst, Robert K.
COVID-19
University of Maryland, Baltimore
University of Maryland, Baltimore. School of Medicine
COVID-19 (Disease)
United States. Defense Advanced Research Projects Agency
Drug Repositioning
Frieman, Matthew B.
Jackson, William T.
Rasko, David A.
Ernst, Robert K.
COVID-19
University of Maryland, Baltimore
University of Maryland, Baltimore. School of Medicine
COVID-19 (Disease)
United States. Defense Advanced Research Projects Agency
Drug Repositioning